跳至主要内容
临床试验/ACTRN12616000961448
ACTRN12616000961448已完成未知

Evaluation of Partnered Pharmacist Medication Charting at Admission: Expansion Project

Alfred Health Pharmacy Department0 个研究点目标入组 15,000 人开始时间: 2016年7月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients admitted to the General Medical unit for inpatient admission
  • Over 18 years of age

排除标准

  • Patients not admitted to the General Medical unit for inpatient admission.

研究者

发起方
Alfred Health Pharmacy Department

相似试验

尚未招募
4 期
This is a comparative clinical trial of two phakic toric lens in patient with Near-sightedness and cylindrical refractive error.
CTRI/2021/12/038930Biotech Healthcare Holdings GmbH
暂停
不适用
Clinical study to evaluate the safety and efficacy of recMAGE-A3 in patients from which the bladder is removed due to muscle invasive bladder cancer.Muscle invasive bladder cancer, radical cystectomy
NL-OMON28470EAU Research Foundation, Arnhem, The Netherlands273
进行中(未招募)
1 期
Evaluation of Pamrevlumab for the Treatment of Male Patients Affected by Non-ambulatory Duchenne Muscular Dystrophy and just Treated with Corticosteroidson-ambulatory Duchenne Muscular DystrophyMedDRA version: 20.0Level: PTClassification code 10013801Term: Duchenne muscular dystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2020-000698-26-ATFibroGen, Inc.92
已完成
不适用
A double-blind, randomised, placebo-controlled phase III study of the efficacy of a bivalent Pseudomonas aeruginosa flagella vaccine in patients with cystic fibrosisNutritional, Metabolic, EndocrineCystic fibrosis
ISRCTN98785888The Society for the fight of Cystic Fibrosis (The Gesellschaft zur Bekämpfung der Mukoviszidose e.V.) (Germany)483
进行中(未招募)
1 期
A study to assess the safety, rationale and effect of a new treatment to improve skin function and wound healing in patients with type 2 diabetesType 2 diabetesMedDRA version: 20.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2017-001351-31-GBniversity of Leeds28